Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients

Journal of Clinical Investigation

Volumn 118, Issue 8, 2008, Pages 2845-2857

  Martínez Llordella, Marc ^a   Lozano, Juan José ^a   Puig Pey, Isabel ^a   Orlando, Giuseppe ^b   Tisone, Giuseppe ^b   Lerut, Jan ^c   Benítez, Carlos ^a   Pons, Jose Antonio ^d   Parrilla, Pascual ^d   Ramírez, Pablo ^d   Bruguera, Miquel ^a   Rimola, Antoni ^a   Sánchez Fueyo, Alberto ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; T LYMPHOCYTE RECEPTOR; TACROLIMUS;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GRAFT RECIPIENT; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE;

EID: 48749084927     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI35342     Document Type: Article

References (35)

1. Lerut, J., and Sanchez-Fueyo, A. 2006. An appraisal of tolerance in liver transplantation. Am. J. Transplant. 6:1774-1780.
2. Starzl, T.E., et al. 1993. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology. 17:1127-1152.
3. Devlin, J., et al. 1998. Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology. 27:926-933.
4. Mazariegos, G.V., et al. 1997. Weaning of immunosuppression in liver transplant recipients. Transplantation. 63:243-249.
5. Pons, J.A., et al. 2003. Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression. Transplantation. 75:1045-1047.
6. Eason, J.D., Cohen, A.J., Nair, S., Alcantera, T., and Loss, G.E. 2005. Tolerance: is it worth the risk? Transplantation. 79:1157-1159.
7. Takatsuki, M., et al. 2001. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation. 72:449-454.
8. Tisone, G., et al. 2006. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J. Hepatol. 44:702-709.
9. Tryphonopoulos, P., et al. 2005. The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. Am. J. Transplant. 5:608-613.
10. Li, Y., et al. 2004. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am. J. Transplant. 4:2118-2125.
11. Martinez-Llordella, M., et al. 2007. Multi-parameter of immune profiling of operational tolerance in liver transplantation. Am. J. Transplant. 7:309-319.
12. Mazariegos, G.V., et al. 2003. Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am. J. Transplant. 3:689-696.
13. O'Brien, R.L., et al. 2007. gammadelta T-cell receptors: functional correlations. Immunol. Rev. 215:77-88.
14. Kress, E., Hedges, J.F., and Jutila, M.A. 2006. Distinct gene expression in human Vdelta1 and Vdelta2 gammadelta T cells following non-TCR agonist stimulation. Mol. Immunol. 43:2002-2011.
15. Fu, Y.X., et al. 1994. Immune protection and control of inflammatory tissue necrosis by gamma delta T cells. J. Immunol. 153:3101-3115.
16. Girardi, M., et al. 2002. Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation. J. Exp. Med. 195:855-867.
17. Szereday, L., Barakonyi, A., Miko, E., Varga, P., and Szekeres-Bartho, J. 2003. Gamma/deltaT-cell subsets, NKG2A expression and apoptosis of Vdelta2+ T cells in pregnant women with or without risk of premature pregnancy termination. Am. J. Reprod. Immunol. 50:490-496.
18. + intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. J. Clin. Invest. 118:281-293.
19. Okabe, K., et al. 2001. CD45RC gammadelta T-cell infiltration is associated with immunologic unresponsiveness induced by prior donor-specific blood transfusion in rat hepatic allografts. Hepatology. 33:877-886.
20. Itohara, S., et al. 1990. Homing of a gamma delta thymocyte subset with homogeneous T-cell receptors to mucosal epithelia. Nature. 343:754-757.
21. Hayday, A., and Tigelaar, R. 2003. Immunoregulation in the tissues by gammadelta T cells. Nat. Rev. Immunol. 3:233-242.
22. Chen, Y., Chou, K., Fuchs, E., Havran, W.L., and Boismenu, R. 2002. Protection of the intestinal mucosa by intraepithelial gamma delta T cells. Proc. Natl. Acad. Sci. U. S. A. 99:14338-14343.
23. Brouard, S., et al. 2007. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc. Natl. Acad. Sci. U. S. A. 104:15448-15453.
24. Alizadeh, A., et al. 1999. The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb. Symp. Quant. Biol. 64:71-78.
25. Bussey, K.J., et al. 2003. MatchMiner: a tool for batch navigation among gene and gene product identifiers. Genome Biol. 4:R27.
26. Louis, S., et al. 2006. Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation. 81:398-407.
27. Hernandez-Fuentes, M., et al. 2007. Biomarkers of tolerance in kidney transplants [abstract]. Am. J. Transplant. 7:340.
28. Wu, Z., Irizarri, R.A., Gentleman, R., Murillo, F.M., and Spencer, F. 2004. A model-based background adjustment for oligonucleotide expression arrays. J. Am. Stat. Assoc. 99:909-917.
29. Johnson, W.E., Li, C., and Rabinovic, A. 2007. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 8:118-127.
30. Tusher, V.G., Tibshirani, R., and Chu, G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98:5116-5121.
31. Tibshirani, R., Hastie, T., Narasimhan, B., and Chu, G. 2002. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. U. S. A. 99:6567-6572.
32. Goeman, J.J., van de Geer, S.A., de Kort, F., and van Houwelingen, H.C. 2004. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics. 20:93-99.
33. Sawitzki, B., et al. 2007. Identification of gene markers for the prediction of allograft rejection or permanent acceptance. Am. J. Transplant. 7:1091-1102.
34. Ocklenburg, F., et al. 2006. UBD, a downstream element of FOXP3, allows the identification of LGALS3, a new marker of human regulatory T cells. Lab. Invest. 86:724-737.
35. Soukup, M., Cho, H., and Lee, J.K. 2005. Robust classification modeling on microarray data using misclassification penalized posterior. Bioinformatics. 21(Suppl. 1):i423-i430.